Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424

scientific article (publication date: June 2006)

Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AHJ.2005.08.015
P698PubMed publication ID16781214

P50authorJohn A. SpertusQ59976170
William E BodenQ60503412
Koon TeoQ60611748
Daniel S BermanQ89697826
Leslee J ShawQ94570815
William S WeintraubQ98158272
Bernard R ChaitmanQ114407034
William J KostukQ114407037
Merril KnudtsonQ114407046
Paul CaspersonQ114407048
P2093author name stringG B John Mancini
David J Maron
Marcin Dada
Pamela M Hartigan
Crystal L Harris
Robert A O'rourke
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectveteranQ193891
revascularizationQ7317735
P304page(s)1173-9
P577publication date2006-06-01
P1433published inAmerican Heart JournalQ2227156
P1476titleDesign and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424
P478volume151

Reverse relations

cites work (P2860)
Q35927515A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina
Q34364029Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).
Q92216896Acute and Long-Term Outcomes of Patients with Impaired Left Ventricular Systolic Function Undergoing Rotational Atherectomy: A Single-Center Observational Retrospective Study
Q92305786Deafening Silence: The Lack of Structured Patient Symptoms in Clinical Documentation of Angina
Q30319078Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery?
Q42632315Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).
Q60921612Endothelial Function: A Short Guide for the Interventional Cardiologist
Q37521237Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
Q45332629Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.
Q59355879How and When to Decide on Revascularization in Stable Ischemic Heart Disease
Q57339258Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society
Q91519288Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes
Q42602556Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug E
Q83181418Medical and Catheter-Based Therapies for Managing Stable Coronary Disease: Lessons From the COURAGE Trial
Q38004987Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics.
Q39249132Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience
Q37140881Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options
Q38845089Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease
Q38552516Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease.
Q26796452Role of short-acting nitroglycerin in the management of ischemic heart disease
Q38212580Stable angina pectoris.
Q33696402The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and [...]
Q41748514Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).

Search more.